Mendez Y, Alpuing Radilla LA, Delgadillo Chabolla LE, Castillo Cruz A, Luna J, Surani S. Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic. World J Diabetes 2023; 14(8): 1178-1193 [PMID: 37664480 DOI: 10.4239/wjd.v14.i8.1178]
Corresponding Author of This Article
Salim Surani, FCCP, MD, MHSc, Academic Editor, Professor, Department of Medicine & Pharmacology, Texas A&M University, 400 Bizzell Street, College Station, TX 77843, United States. Surani@tmau.edu
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Aug 15, 2023; 14(8): 1178-1193 Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1178
Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic
Yamely Mendez, Linda A Alpuing Radilla, Luis Eduardo Delgadillo Chabolla, Alejandra Castillo Cruz, Johanan Luna, Salim Surani
Yamely Mendez, Linda A Alpuing Radilla, Luis Eduardo Delgadillo Chabolla, Alejandra Castillo Cruz, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030, United States
Johanan Luna, Department of Medicine, Xochicalco University, Mexicali 21376, BC, Mexico
Johanan Luna, Department of Medicine, Mt. Olympus Medical Research, Sugarland, TX 77479, United States
Salim Surani, Department of Medicine & Pharmacology, Texas A&M University, College Station, TX 77843, United States
Author contributions: All authors equally contributed to this paper with the conception and design of the study, literature review and analysis, manuscript drafting, critical revision, and editing, and final approval of the definitive version.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Salim Surani, FCCP, MD, MHSc, Academic Editor, Professor, Department of Medicine & Pharmacology, Texas A&M University, 400 Bizzell Street, College Station, TX 77843, United States. Surani@tmau.edu
Received: May 28, 2023 Peer-review started: May 28, 2023 First decision: June 13, 2023 Revised: June 24, 2023 Accepted: July 17, 2023 Article in press: July 17, 2023 Published online: August 15, 2023 Processing time: 74 Days and 15.8 Hours
Abstract
During the global coronavirus disease 2019 (COVID-19) pandemic, people worldwide have experienced an unprecedented rise in psychological distress and anxiety. In addition to this challenging situation, the prevalence of diabetes mellitus (DM), a hidden epidemic, has been steadily increasing in recent years. Lower-middle-income countries have faced significant barriers in providing accessible prenatal care and promoting a healthy diet for pregnant women, and the pandemic has made these challenges even more difficult to overcome. Pregnant women are at a higher risk of developing complications such as hyper-tension, preeclampsia, and gestational diabetes, all of which can have adverse implications for both maternal and fetal health. The occurrence of gestational diabetes has been on the rise, and it is possible that the pandemic has worsened its prevalence. Although data is limited, studies conducted in Italy and Canada suggest that the pandemic has had an impact on gestational diabetes rates, especially among women in their first trimester of pregnancy. The significant disruptions to daily routines caused by the pandemic, such as limited exercise options, indicate a possible link between COVID-19 and an increased likelihood of experiencing higher levels of weight gain during pregnancy. Notably, individuals in the United States with singleton pregnancies are at a significantly higher risk of excessive gestational weight gain, making this association particularly important to consider. Although comprehensive data is currently lacking, it is important for clinical researchers to explore the possibility of establishing correlations between the stress experienced during the pandemic, its consequences such as gestational gain weight, and the increasing incidence of gestational DM. This knowledge would contribute to better preventive measures and support for pregnant individuals during challenging times.
Core Tip: The coronavirus disease 2019 pandemic has caused a rise in psychological distress on a global scale, overlapping with an increase in cases of diabetes mellitus. Women, in particular those residing in lower-middle-income countries, stumble upon difficulties for a decent prenatal care and maintaining nutritious diets. Pregnant women who have a higher susceptibility to gestational diabetes may face long-term health consequences for both them and their unborn child. Recent studies suggest a potential link between the pandemic and elevated rates of gestational diabetes. Additional research is necessary to establish a conclusive correlation between the impact of pandemic-induced stress, gestational gain weight, and the outcomes of pregnancies affected by gestational diabetes.